Publications by Residents
Selected Key Publications
Chung EM, Lu DJ, Nguyen AT, Hendifar AE, Nissen NN, Gong J, Osipov A, Gangi A, Attiyeh MA, Atkins KM, Kamrava M. Patterns of Failure in Patients With Borderline Resectable/Locally Advanced Pancreatic Cancer After Preoperative Chemotherapy and Stereotactic Body Radiation Therapy. Adv Radiat Oncol. 2024 Feb 12; 9(5): 101471.
Zhang SC, Silos KD, Gasho JO, Peony O, Polishchuk T, Semaan L, Stiehl B, Hakimian B, Mirhadi A, Kamrava M, Guthier C, Nikolova A, McKenzi E, Steers J, Mak RH, Atkins KM. Feasibility of Left Anterior Descending Coronary Artery Sparing Radiation Therapy for Locally Advanced Lung Cancer. Pract Radiat Oncol. 2024 Jul 4; S1879-8500(24)00143-7.
Zhang SC, Nikolova A, Kamrava M, Mak RH, Atkins KM. J Med Imaging Radiat Oncol. 2024 Jul 10.
Chung EM, Nguyen AT, Mirhadi AJ, Steers JM, Phillips T, Atkins KM, Burnison M, Shiao SL, Kamrava M. A Single-Institution Retrospective Study of Three-Fraction HDR Accelerated Partial Breast Irradiation. Brachytherapy 2023 May-Jun;22(3):361-367.
Anderson EM, Luu M, Chung EM, Gay C, Mallen-St Clair J, Jo AS, Zumsteg ZS. Re-examining predictors of pathologic lymph node positivity in clinically node negative oral cavity cancer. Oral Oncol 2023 Sep;144:106490.
Zhang SC, Tjong MC, Gasho JO, Silos KD, Gay C, McKenzie EM, Steers J, Bitterman DS, Nikolova, AP, Nohria A, Hoffmann U, Brantley KD, Mak RH, Atkins KM. External validation of C ardiac disease, H ypertension, and L ogarithmic L eft anterior descending coronary artery radiation dose (CHyLL) for predicting major adverse cardiac events after lung cancer radiotherapy. Clin Transl Radiat Oncol. 2023 Sep.
Zhang SC, Chau BL, LaGuardia JS, Kim Sungjin, Pletcher E, Sanford NN, Raldwo AC, Snger L, Gong J, Padda SK, Kamrava M, Cohen T, Atkins KM. Association of Parental Status and Gender With Burden of Multidisciplinary Tumor Boards Among Oncology Physicians. JAMA Netw Open. 2023 Oct 2; 6(10).
Chung EM, Zhang SC, Nguyen AT, Atkins KM, Sandler HM, Kamrava M. Feasibility and acceptability of ChatGPT generated radiology report summaries for cancer patients. Digit Health. 2023 Dec 19.
Zhang SC, Shin A, Gasho JO, Silos KD, Polishchuk T, Bennett J, Kamrava M, Guthier CV, Nikolova A, Steers J, Mak RH, Lewis JH, Atkins KM. Left Anterior Descending Coronary Artery-Optimized Knowledge-Based Radiotherapy Planning in Patients with Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phy. 2023 Oct 1. E718.
Zhang SC, Schmidt G, Paquette RK, Hakimian B, Ballas LK. Real World Utilization of Cranial or Craniospinal Radiation in Adult Acute Lymphoid Leukemia Patients: Data from the Center for International Blood and Marrow Transplant Research. Int J Radiat Oncol Biol Phy. 2023 Oct 1; E496-E497.
Lu DJ, Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, Gay C, Chen MM, Chaturvedi AK, Goodman MT. Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst. 2023 Dec 6. 115(12):1544-1554.
Lu DJ, Atkins KM, Small Jr W, Kamrava M. Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost. Brachytherapy. 2022 Jan-Feb;21(1):22-28.
Nguyen AT, Kamrava A. Re: Jana S. Hopstaken, Joyce G.R. Bomers, Michiel J.P. Sedelaar, Massimo Valerio, Jurgen J. Fütterer, Maroeska M. Rovers. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol. 2021;81:5-33. Eur Urol. 2022 Feb;81(2):e48-e49.
Cerda VR, Lu DJ, Scott M, Him KH, Rimel BJ, Kamrava M. Evaluation of patterns of progression on poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance in ovarian cancer: a cross-sectional study. Int J Gynecol Cancer. 2022 Feb;32(2):153-158.
Anderson EM, Luu M, Lu DJ, Chung EM, Kamrava M. Pathologic primary tumor factors associated with risk of lymph node involvement in patients with non-endometrioid endometrial cancer. Gyencol Oncol. 2022 May;165(2):281-286.
Nguyen AT, Atkins KA, Kamrava, M. In Regard to Apisarnthanarax et al. Pract Radiat Oncol. 2022 May-Jun;12(3):e239.
Nguyen AT, Kim S, Keyes M, Petereit DG, Mourtada F, Rossi PJ, Klopp AH, Kamrava M. Evaluation of burnout in physician members of the American Brachytherapy Society. Brachytherapy. 2022 May-Jun;21(3):362-368.
Nguyen AT, Luu M, Nguyen VP, Lu DJ, Shiao SL, Kamrava M, Atkins KM, Mita AC, Scher KS, Spratt DE, et al. Quantitative Nodal Burden and Mortality Across Solid Cancers. J Natl Center Inst. 2022 Jul 11;114(7):1003-1011.
Lu DJ, Luu M, Gay C, Nguyen AT, Anderson EM, Bernier J, Cooper JS, Harari PM, Torres-Saavedra PA, Le QT, et al. Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931. Int J Radiat Oncol Biol Phy 2022 Jul 15;113(4):787-795.
Anderson EA, Gu L, Oyekunle T, De Hoedtm AM, Wiggins E, Gay CJ, Lu DJ, Daskivich TJ, Freedland SJ, Zumsteg ZS, Csizmadi I. Lifestyle and sociodemographic factors associated with treatment choice of clinically localized prostate cancer in an equal access healthcare system. Prostate Cancer Prostatic Dis 2022 Sept; 25(3):593-595.
Chung EM, Gong J, Zaghiyan K, Kamrava M, Atkins KA. Local Therapies for Colorectal Cancer Oligometastases to the Lung. Curr Colorectal Cancer Rep 2022 Jun; 18:45-53.
Anderson, EA, Luu M, Lu DJ, Chung EM, Gay C, Scher KS, Mita AC, Mallen-St. Clair J, Ho AS, Zumsteg ZS. Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers. Epub 2022 Aug 3.
Zhang SC, Gay C, Mckenzie E, Kim S, Polischuk T, Hargens B, Semaan-Corbett L, Bennett J, Shai Savandi SA, Soliz C, Park H, Hakimian B, Mirhadi AJ, Kamrava M, Padda S, Nikolova A, Mak RH, Atkins KM. Correlation of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Feasibility of Coronary Artery Sparing Treatment Planning in Lung Cancer. 2022 Nov 1; 114(3):166.
Nguyen AT, Luu M, Chung EM, Lu DJ, Mita A, Mirhadi AJ, Atkins KM, Zumsteg ZS. Derivation of a Modified Novel Pathologic Nodal Classification System for Non-Small Cell Lung Cancer. 2022 Nov 1; 114(3): 2862.
McKenzie EM, Zhang SC, Zakariaee R, Guthier CV, Hakimian B, Mirhadi AJ, Kamrava M, Padda SK, Lewis JH, Nikolova A, Mak RH, Atkins KM. Left Anterior Descending Coronary Artery Radiation Dose Association With All-Cause Mortality in NRG Oncology Trial RTOG 0617. Epub 2022 Nov 24.
Nguyen AT, Dar TB, Viramontes J, Mevises NY, Biteghe FN, Stevens S, Kershaw K, De Simone M, Ko E, Lu DJ, Chung EM, Zhang SC, Atkins KM, Kamrava M, Sandler HM, Guarnerio J, Knott S, Zumsteg ZS, Shiao SL. Phagocytosis Checkpoint Blockade Overcomes Immunosuppression Triggered by Radiation Therapy and PD1 Inhibition. Int J Radiat Oncol Biol Phy 2022 Nov 1;114(3):541.
Chung EM, Kim S, Zhang SC, Nguyen AT, Lu DJ, Atkins KM, Kamrava M. Trends and Disparities in Telehealth Utilization for Cancer Care during COVID-19. Int J Radiat Oncol Biol Phy 2022 Nov 1;114(3):e131-e132.
Zhang SC, Atkins KM, Chung EM, Kamrava M. Emerging Role of Brachytherapy in the Non-operative Management of Rectal Cancer. Curr Colorectal Cancer Rep 2022 Nov 11; 18:68-74.
Nguyen AT, Chung-Tang SL, Kamrava M. A "scoping" review of prostate brachytherapy and immune responses. Epub 2022 Nov 25.
Lu DJ, Girgis M, David JM, Chung EM, Atkins KM, Kamrava M. Evaluation of Mobile Health Applications to Track Patient-Reported Outcomes for Oncology Patients: A Systematic Review. Adv Radiat Oncol. 2021 Jan-Feb;6(1):100576.
Lu DJ, King B, Sandler HM, Tarbell NJ, Kamrava M, Atkins KM. Paid Parental Leave Policies Among U.S. News & World Report 2020-2021 Best Hospitals and Best Hospitals for Cancer. JAMA Netw Open. 2021 May 3;4(5):e218518.
Anderson EM, Luu M, Balzer BL, Scher KS, Mita AC, Lu DJ, Shiao SL, Clair JM, Ho AS, Zumsteg ZS. Variations in the association of grade with survival across the head and neck cancer landscape. Head Neck. 2021 Apr;43(4):1105-1115.
Nguyen AT, Shiao SL, McArthur HL. Advances in Combining Radiation and Immunotherapy in Breast Cancer. Clin Breast Cancer. 2021 Apr;21(2):143-152.
Ho AS, Luu M, Kim S, Tighiouart M, Mita AC, Scher KS, Mallen-St Clair J, Walgama ES, Lin DC, Nguyen AT, Zumsteg ZS. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma. Cancer. 2021 May 15;127(10):1590-1597.
Anderson EM, Kim S, Sandler HM, Kamrava M. High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis. J Contemp Brachytherapy. 2021 Aug;13(4):365-372.
Lu DJ, Gay C, Raphael YR, Steers J, Lewis JH, DeMarco J, Fraass B, Rimel BJ, Zakariaee R, Kamrava M, Atkins KM. Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis. Adv Radiat Oncol. 2021 Oct 24;7(1):100804.
Nguyen AT, Lu DJ, Luu M, Nguyen VP, Hamid O, Faries MB, Gharavi NM, Mallen-St Clair J, Ho AS, Zumsteg ZS. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma. JAMA Surg. 2021 Nov 1;156(11):e214298.
Nguyen AT, Luu M, Nugyen VP, Lu DJ, Shiao SL, Kamrava M, Atkins KM, Mita A, Scher K, Spratt DE, et al. The Universality of Parallel Increasing Quantitative Nodal Burden and Mortality Across Solid Cancers. Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):e103.
Anderson EM, LeVee A, Kim S, Atkins KM, Guan M, Placencio-Hickok V, Moshayedi N, Hendifar A, Ospov A, Gangi A, et al. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. JAMA Netw Open. 2021 Dec 1;4(12):e2138432.
David JM, Luu M, Lu DJ, Zumsteg ZS, Sandler H, Kamrava M. Outcomes with brachytherapy based dose escalation for gleason 8 versus 9-10 prostate cancer: An NCDB analysis. Urol Oncol. 2021 Dec;39(12):829.e19-829.e26.
Anderson EM, Park K, Lu DJ, Nissen N, Gong J, Hendifar A, Gangi A, Lo S, Kamrava M, Atkins KM. A radiopaque polymer hydrogel as an irreversible electroporation compatible fiducial marker for pancreas stereotactic body radiotherapy. J Radiosurg SBRT. 2020;7(2):165-167.
Sinha S, Lazar A, Lam A, Anderson EM, Chen LM, Hsu IJ, Yoshida EJ. Adjuvant radiation followed by chemotherapy is associated with improved overall survival in endometrial cancer. Gynecol Oncol. 2020 Oct;159(1):30-35.
Nguyen AT, Luu M, Mallen-St. Clair J, Mita A, Scher K, Lu DJ, Shiao SL, Ho AS, Zumsteg ZS. Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell Carcinoma. JAMA Oncol. Published online August 20, 2020.
Anderson EM, David JM, Phillips T, DemarcoJ, Reznik RS, Mirhadi AJ, Kamrava M. Interstitial high-dose-rate brachytherapy in the treatment of keloids: Moving toward a volumetric approach. Brachytherapy. 2020;S1538-4721(20)30145-8. Advance online publication.
Lu DJ, Luu M, Nguyen AT, Shiao SL, Scher K, Mita A, Anderson EM, Mallen-St. Clair J, Ho AS, Zumsteg ZS, et al. The role of concomitant chemoradiotherapy in AJCC 7th edition T1-2N1 oropharyngeal carcinoma in the human papillomavirus era. Oral Oncology. [published online ahead of print, 2020 Jul 7].
Tam M, Luu M, Barker CA, Lu DJ, Ho AS, Zumsteg ZS. Improved survival in women versus men with merkel cell carcinoma. J Am Acad Dermatol. 2020 May 15;S0190-9622(20)30273-5.
Monjazeb AM, Schalper KA, Villarroel-Espindola F, Nguyen AT, Shiao SL, Young K. Effects of Radiation on the Tumor Microenvironment. Semin Radiat Oncol. 2020;30(2):145-157.
Tuli R, David JM, Lobaugh S, Zhang Z, O'Reilly EM. Duration of therapy for locally advanced pancreatic cancer: Does it matter? Cancer Med. 2020 Jul;9(13):4572-4580. PMID: 32368871; PMCID: PMC7333837.
Gartland RM, Myers LC, Iorgulescu JB, Nguyen AT, Yu-Moe CW, Falcone B, Mitchell R, Kachalia A, Mort E. Body of Evidence. Do Autopsy Findings Impact Medical Malpractice Claim Outcomes? Journal of Patient Safety. 2020 March 23.
Lu DJ, Phillips T, DeMarco J, Sandler HM, Kamrava M. A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy. Brachytherapy. 2020;19(2):216-221.
Nguyen AT, Luu M, Lu DJ, Hamid O, Mallen-St Clair J, Faries MB, Gharavi NM, Ho AS, Zumsteg ZS. Quantitative metastatic lymph node burden and survival in Merkel cell carcinoma. J Am Acad Dermatol. 2020;S0190-9622(20)30062-1.
Lu DJ, Luu M, Nguyen AT, Scher KS, Clair JM, Mita A, Shiao SL, Ho AS, Zumsteg ZS. Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence. Oral Oncology. 2019;99, 104472.
Sittig MP, Luu M, Yoshida EJ, Scher K, Mita A, Shiao SL, Lu DJ, Mallen-St Clair J, Ho AS, Zumsteg ZS. Impact of insurance on survival in patients < 65 with head and neck cancer treated with radiotherapy [published online ahead of print October 29, 2019]. Clin Otolaryngol. 2019 Oct 29.
Yoshida EJ, Luu M, Mallen-St Clair J, Mita AC, Scher KS, Lu DJ, Nguyen AT, Shiao SL, Ho AS, Zumsteg ZS. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments? [published online ahead of print September 19, 2019]. Cancer. 2019 Sep 19.
Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Yoshida EJ, Mallen-St Clair J, Shiao SL, Leivo I, Zumsteg ZS. Survival impact of adjuvant therapy in salivary gland cancers following resection and neck dissection. Otolaryngol Head Neck Surg. 2019 Jun;160(6):1048-1057.
Lu DJ, Luu M, Nguyen AT, Scher KS, Clair JM, Mita A, Shiao SL, Ho AS, Zumsteg ZS. Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence. Oral Oncol. 2019 Nov 5;99:104472.
Lu DJ, Luu M, Yashar CM, Klopp AH, Kamrava M. An evaluation of gender diversity in the American Brachytherapy Society. Brachytherapy. 2019 Nov-Dec;18(6):835-840.
Zumsteg ZS, Luu M, Kim S, Tighiouart M, Mita A, Scher KS, Lu DJ, Shiao SL, Mallen-St Clair J, Ho AS. Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation. Ann Oncol. 2019 Oct 1;30(10):1669.
David JM, Yue Y, Blas K, Hendifar A, Kabolizadeh P, Tuli R. 18F-FDG PET predicts hematologic toxicity in patients with locally advanced anal cancer treated with chemoradiation. Adv Radiat Oncol. 2019 Oct-Dec;4(4):613-622.
Guan M, He I, Luu M, David JM, Gong J, Placencio-Hickok VR, Reznik RS, Tuli R, Hendifar AE. Palliative radiation therapy for bone metastases in neuroendocrine neoplasms. Adv Radiat Oncol. 2019 Jul-Dec;4(3):513-519.
Toll SA, Jones MT, Yoshida EJ, Dhall G, Olch AJ, Wong KK. The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors. Pediatr Blood Cancer. 2019 Dec;66(12):e28005.
Lam A, Yoshida EJ, Bui K, Katrivesis J, Fernando D, Nelson K, Abi-Jaoudeh N. Demographic and facility volume related outcomes in radiofrequency ablation for early-stage hepatocellular carcinoma. HPB (Oxford). 2019 Jul;21(7):849-856.
David JM, Kamrava M. In Regard to Peters et al. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1182-1183.
David JM, Kamrava M. Letter to the Editor Regarding: Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation with Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy. Pract Radiat Oncol. 2019 Mar;9(2):59.
David JM, Kamrava M. Prostate Cancer Radiotherapy: An Evolving Paradigm That Should Also Include High-Dose-Rate Monotherapy. J Clin Oncol. 2019 Feb 10;37(5):441.
David JM, Lao Y, Torosian A, Placencio V, Wang Y, Hendifar A, Yang W, Tuli R. Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma. Phys Imaging Radiat Oncol. 2019 Jan;9:28-34.
Have Questions or Need Help?
Contact us if you would like to learn more about the Radiation Oncology Residency Program at Cedars-Sinai.